Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dino Luethi

23PUBLICATIONS
58CO-AUTHORS
Toxicology (incl. clinical toxicology)Biologically active moleculesCharacterisation of biological macromoleculesMolecular medicineCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

Sort by Publication Date:
|Jun 04, 2026
Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

|May 05, 2026
5-HT<sub>2A</sub> receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence.

|Apr 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

|Mar 28, 2026
Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants.

Livio Erne, Lorenz Mueller, Isabelle Straumann

|Nov 05, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Dino Luethi, Grant C Glatfelter, Eline Pottie

|Sep 25, 2025
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants.

Isabelle Straumann, Patrick Vizeli, Isidora Avedisian

Pageof 4

Frequent Collaborators

17 joint publications

Matthias E Liechti

9 joint publications

Deborah Rudin

8 joint publications

Anne Eckert

6 joint publications

Lorenz Müller

6 joint publications

Harald H Sitte

5 joint publications

Jan Thomann

4 joint publications

Friederike Holze

4 joint publications

Anna M Becker

3 joint publications

Jae-Won Yang

3 joint publications

Thomas Stockner

Frequent Collaborators

17 joint publications

Matthias E Liechti

9 joint publications

Deborah Rudin

8 joint publications

Anne Eckert

6 joint publications

Lorenz Müller